Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9

The major barrier to HIV-1 cure is the persistence of latent provirus, which is not eradicated by antiretroviral therapy. The “shock and kill” approach entails stimulating viral production with latency-reversing agents followed by the killing of cells actively producing the virus by immune clearance...

Full description

Bibliographic Details
Main Authors: Alex Olson, Binita Basukala, Seunghee Lee, Matthew Gagne, Wilson W. Wong, Andrew J. Henderson
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/10/1154
_version_ 1827704486725943296
author Alex Olson
Binita Basukala
Seunghee Lee
Matthew Gagne
Wilson W. Wong
Andrew J. Henderson
author_facet Alex Olson
Binita Basukala
Seunghee Lee
Matthew Gagne
Wilson W. Wong
Andrew J. Henderson
author_sort Alex Olson
collection DOAJ
description The major barrier to HIV-1 cure is the persistence of latent provirus, which is not eradicated by antiretroviral therapy. The “shock and kill” approach entails stimulating viral production with latency-reversing agents followed by the killing of cells actively producing the virus by immune clearance. However, this approach does not induce all intact proviruses, leaving a residual reservoir. CRISPR/Cas9 has been utilized to excise integrated Human Immunodeficiency Virus (HIV) DNA from infected cells in an RNA-guided, sequence-specific manner. Here, we seek to epigenetically silence the proviral DNA by introducing nuclease-deficient disabled Cas9 (dCas9) coupled with a transcriptional repressor domain derived from Kruppel-associated box (KRAB). We show that specific guide RNAs (gRNAs) and dCas9-KRAB repress HIV-1 transcription and reactivation of latent HIV-1 provirus. This repression is correlated with chromatin changes, including decreased H3 histone acetylation and increased histone H3 lysine 9 trimethylation, histone marks that are associated with transcriptional repression. dCas9-KRAB-mediated inhibition of HIV-1 transcription suggests that CRISPR can be engineered as a tool for block-and-lock strategies.
first_indexed 2024-03-10T15:42:19Z
format Article
id doaj.art-5b325f9e84c34508ae8e6955b0c8362d
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T15:42:19Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-5b325f9e84c34508ae8e6955b0c8362d2023-11-20T16:45:03ZengMDPI AGViruses1999-49152020-10-011210115410.3390/v12101154Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9Alex Olson0Binita Basukala1Seunghee Lee2Matthew Gagne3Wilson W. Wong4Andrew J. Henderson5Department of Medicine and Microbiology, Boston University School of Medicine, Boston, MA 02118, USADepartment of Biology, Boston University, Boston, MA 02215, USABiomedical Engineering and Biological Design Center, Boston University, Boston, MA 02215, USADepartment of Medicine and Microbiology, Boston University School of Medicine, Boston, MA 02118, USABiomedical Engineering and Biological Design Center, Boston University, Boston, MA 02215, USADepartment of Medicine and Microbiology, Boston University School of Medicine, Boston, MA 02118, USAThe major barrier to HIV-1 cure is the persistence of latent provirus, which is not eradicated by antiretroviral therapy. The “shock and kill” approach entails stimulating viral production with latency-reversing agents followed by the killing of cells actively producing the virus by immune clearance. However, this approach does not induce all intact proviruses, leaving a residual reservoir. CRISPR/Cas9 has been utilized to excise integrated Human Immunodeficiency Virus (HIV) DNA from infected cells in an RNA-guided, sequence-specific manner. Here, we seek to epigenetically silence the proviral DNA by introducing nuclease-deficient disabled Cas9 (dCas9) coupled with a transcriptional repressor domain derived from Kruppel-associated box (KRAB). We show that specific guide RNAs (gRNAs) and dCas9-KRAB repress HIV-1 transcription and reactivation of latent HIV-1 provirus. This repression is correlated with chromatin changes, including decreased H3 histone acetylation and increased histone H3 lysine 9 trimethylation, histone marks that are associated with transcriptional repression. dCas9-KRAB-mediated inhibition of HIV-1 transcription suggests that CRISPR can be engineered as a tool for block-and-lock strategies.https://www.mdpi.com/1999-4915/12/10/1154HIV transcriptionHIV latencyCRISPRchromatin
spellingShingle Alex Olson
Binita Basukala
Seunghee Lee
Matthew Gagne
Wilson W. Wong
Andrew J. Henderson
Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
Viruses
HIV transcription
HIV latency
CRISPR
chromatin
title Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
title_full Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
title_fullStr Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
title_full_unstemmed Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
title_short Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
title_sort targeted chromatinization and repression of hiv 1 provirus transcription with repurposed crispr cas9
topic HIV transcription
HIV latency
CRISPR
chromatin
url https://www.mdpi.com/1999-4915/12/10/1154
work_keys_str_mv AT alexolson targetedchromatinizationandrepressionofhiv1provirustranscriptionwithrepurposedcrisprcas9
AT binitabasukala targetedchromatinizationandrepressionofhiv1provirustranscriptionwithrepurposedcrisprcas9
AT seungheelee targetedchromatinizationandrepressionofhiv1provirustranscriptionwithrepurposedcrisprcas9
AT matthewgagne targetedchromatinizationandrepressionofhiv1provirustranscriptionwithrepurposedcrisprcas9
AT wilsonwwong targetedchromatinizationandrepressionofhiv1provirustranscriptionwithrepurposedcrisprcas9
AT andrewjhenderson targetedchromatinizationandrepressionofhiv1provirustranscriptionwithrepurposedcrisprcas9